doi: 10.1128/AAC.37.5.1184.
In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations
Affiliations
- PMID: 8517712
- PMCID: PMC187929
- DOI: 10.1128/AAC.37.5.1184
Item in Clipboard
In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations
Antimicrob Agents Chemother.
1993 May.
Erratum in
- Antimicrob Agents Chemother 1993 Sep;37(9):2044
Abstract
Synergy between metronidazole and its hydroxymetabolite and between each compound and amoxicillin or tetracycline-HCl was determined against Helicobacter pylori. Metronidazole plus its hydroxymetabolite and either compound combined with amoxicillin showed synergism against all 10 strains of H. pylori tested. Metronidazole plus tetracycline-HCl or the hydroxymetabolite plus tetracycline-HCl acted synergistically against seven and six strains, respectively, acted additively against three strains, and had no additional effect against one strain. These results may help to explain the in vivo efficacies of metronidazole combinations in the treatment of H. pylori-associated gastritis.
Similar articles
-
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.J Med Microbiol. 2000 May;49(5):415-418. doi: 10.1099/0022-1317-49-5-415. J Med Microbiol. 2000. PMID: 10798553
-
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.Helicobacter. 2018 Dec;23(6):e12545. doi: 10.1111/hel.12545. Epub 2018 Oct 16. Helicobacter. 2018. PMID: 30324756
-
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.Helicobacter. 1996 Mar;1(1):57-61. doi: 10.1111/j.1523-5378.1996.tb00009.x. Helicobacter. 1996. PMID: 9398914
-
In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.Antimicrob Agents Chemother. 2000 Sep;44(9):2518-20. doi: 10.1128/AAC.44.9.2518-2520.2000. Antimicrob Agents Chemother. 2000. PMID: 10952605 Free PMC article.
-
Quinone Derivatives as Promising Anti-Helicobacter pylori Agents from Aerial Parts of Mitracarpus hirtus.J Nat Prod. 2022 Apr 22;85(4):1029-1038. doi: 10.1021/acs.jnatprod.1c01163. Epub 2022 Apr 12. J Nat Prod. 2022. PMID: 35412828 Review.
Cited by
-
Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection.Clin Diagn Lab Immunol. 2004 May;11(3):569-76. doi: 10.1128/CDLI.11.3.569-576.2004. Clin Diagn Lab Immunol. 2004. PMID: 15138184 Free PMC article.
-
Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori.Antimicrob Agents Chemother. 1994 Oct;38(10):2357-61. doi: 10.1128/AAC.38.10.2357. Antimicrob Agents Chemother. 1994. PMID: 7840570 Free PMC article. Clinical Trial.
-
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.Antimicrob Agents Chemother. 2002 May;46(5):1435-40. doi: 10.1128/AAC.46.5.1435-1440.2002. Antimicrob Agents Chemother. 2002. PMID: 11959579 Free PMC article.
-
A low prevalence of H pylori and endoscopic findings in HIV-positive Chinese patients with gastrointestinal symptoms.World J Gastroenterol. 2007 Nov 7;13(41):5492-6. doi: 10.3748/wjg.v13.i41.5492. World J Gastroenterol. 2007. PMID: 17907294 Free PMC article.
-
Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant Helicobacter pylori.Antibiotics (Basel). 2020 Sep 30;9(10):658. doi: 10.3390/antibiotics9100658. Antibiotics (Basel). 2020. PMID: 33007899 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
